Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial - Archive ouverte HAL Access content directly
Journal Articles European Journal of Nutrition Year : 2021

Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial

(1) , (1) , (2) , (3) , (1) , (1) , (1) , (1) , (1, 4) , (5) , (6) , (7) , (7) , (1) , (3) , (2, 8) , (1) , (1)
1
2
3
4
5
6
7
8
Z. Zhang
N. Paquot
  • Function : Author

Abstract

PURPOSE: Inulin-type fructans (ITF) are prebiotic dietary fibre (DF) that may confer beneficial health effects, by interacting with the gut microbiota. We have tested the hypothesis that a dietary intervention promoting inulin intake versus placebo influences fecal microbial-derived metabolites and markers related to gut integrity and inflammation in obese patients. METHODS: Microbiota (16S rRNA sequencing), long- and short-chain fatty acids (LCFA, SCFA), bile acids, zonulin, and calprotectin were analyzed in fecal samples obtained from obese patients included in a randomized, placebo-controlled trial. Participants received either 16 g/d native inulin (prebiotic n = 12) versus maltodextrin (placebo n = 12), coupled to dietary advice to consume inulin-rich versus inulin-poor vegetables for 3 months, in addition to dietary caloric restriction. RESULTS: Both placebo and prebiotic interventions lowered energy and protein intake. A substantial increase in Bifidobacterium was detected after ITF treatment (q = 0.049) supporting our recent data obtained in a larger cohort. Interestingly, fecal calprotectin, a marker of gut inflammation, was reduced upon ITF treatment. Both prebiotic and placebo interventions increased the ratio of tauro-conjugated/free bile acids in feces. Prebiotic treatment did not significantly modify fecal SCFA content but it increased fecal rumenic acid, a conjugated linoleic acid (cis-9, trans-11 CLA) with immunomodulatory properties, that correlated notably to the expansion of Bifidobacterium (p = 0.031; r = 0.052). CONCLUSIONS: Our study demonstrates that ITF-prebiotic intake during 3 months decreases a fecal marker of intestinal inflammation in obese patients. Our data point to a potential contribution of microbial lipid-derived metabolites in gastro-intestinal dysfunction related to obesity. CLINICALTRIALS. GOV IDENTIFIER: NCT03852069 (February 22, 2019 retrospectively, registered).
Fichier principal
Vignette du fichier
Neyrinck2021_Article_PrebioticDietaryFibreIntervent.pdf (887.92 Ko) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-03282703 , version 1 (09-07-2021)

Identifiers

Cite

A. M. Neyrinck, J. Rodriguez, Z. Zhang, B. Seethaler, C. R. Sánchez, et al.. Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial. European Journal of Nutrition, 2021, Online ahead of print. ⟨10.1007/s00394-021-02484-5⟩. ⟨inserm-03282703⟩
15 View
25 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More